Found: 42
Select item for more details and to access through your institution.
HDL-targeted therapies: progress, failures and future.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 6, p. 445, doi. 10.1038/nrd4279
- By:
- Publication type:
- Article
Amyloid-β: Acute-phase apolipoprotein with metal-binding activity.
- Published in:
- Journal of Alzheimer's Disease, 2005, v. 8, n. 2, p. 129, doi. 10.3233/JAD-2005-8205
- By:
- Publication type:
- Article
Alterations of HDL particle phospholipid composition and role of inflammation in rheumatoid arthritis.
- Published in:
- Journal of Physiology & Biochemistry, 2019, v. 75, n. 4, p. 453, doi. 10.1007/s13105-019-00694-4
- By:
- Publication type:
- Article
Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosis.
- Published in:
- Archives of Medical Science, 2023, v. 19, n. 1, p. 57, doi. 10.5114/aoms/140728
- By:
- Publication type:
- Article
Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 719, doi. 10.3390/ijms22020719
- By:
- Publication type:
- Article
Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 2, p. 197, doi. 10.3390/metabo13020197
- By:
- Publication type:
- Article
Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/metabo12070623
- By:
- Publication type:
- Article
The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 5, p. 460, doi. 10.3390/metabo12050460
- By:
- Publication type:
- Article
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320959248
- By:
- Publication type:
- Article
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, p. 1, doi. 10.1177/2040622320959248
- By:
- Publication type:
- Article
Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 4, p. 416, doi. 10.1038/nsmb.2028
- By:
- Publication type:
- Article
High-Density Lipoprotein (HDL) Particle Subpopulations in Heterozygous Cholesteryl Ester Transfer Protein (CETP) Deficiency: Maintenance of Antioxidative Activity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049336
- By:
- Publication type:
- Article
neutrophil–lymphocyte ratio and incident atherosclerotic events: the impact of racial differences?
- Published in:
- European Heart Journal, 2021, v. 42, n. 39, p. 4092, doi. 10.1093/eurheartj/ehab256
- By:
- Publication type:
- Article
Lipidomics as a Tool for the Study of Lipoprotein Metabolism.
- Published in:
- Current Atherosclerosis Reports, 2010, v. 12, n. 3, p. 194, doi. 10.1007/s11883-010-0100-0
- By:
- Publication type:
- Article
Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.
- Published in:
- Current Atherosclerosis Reports, 2006, v. 8, n. 6, p. 501, doi. 10.1007/s11883-006-0026-8
- By:
- Publication type:
- Article
Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 10, p. 4963, doi. 10.1210/jc.2004-0305
- By:
- Publication type:
- Article
Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1031, n. 1, p. 249, doi. 10.1196/annals.1331.025
- By:
- Publication type:
- Article
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.
- Published in:
- European Heart Journal, 2010, v. 31, n. 2, p. 149, doi. 10.1093/eurheartj/ehp399
- By:
- Publication type:
- Article
HDL-mediated mechanisms of protection in cardiovascular disease.
- Published in:
- Cardiovascular Research, 2014, v. 103, n. 3, p. 341, doi. 10.1093/cvr/cvu147
- By:
- Publication type:
- Article
Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload.
- Published in:
- Clinical Science, 2015, v. 128, n. 9, p. 609, doi. 10.1042/CS20140300
- By:
- Publication type:
- Article
Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I.
- Published in:
- Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 3, p. 608, doi. 10.1111/j.1582-4934.2009.00713.x
- By:
- Publication type:
- Article
Phosphatidylserine enhances anti‐inflammatory effects of reconstituted HDL in macrophages via distinct intracellular pathways.
- Published in:
- FASEB Journal, 2022, v. 36, n. 5, p. 1, doi. 10.1096/fj.201800810R
- By:
- Publication type:
- Article
Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity.
- Published in:
- FASEB Journal, 2019, v. 33, n. 4, p. 4741, doi. 10.1096/fj.201801897R
- By:
- Publication type:
- Article
Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin.
- Published in:
- FASEB Journal, 2018, v. 32, n. 3, p. 1602, doi. 10.1096/fj.201600298RR
- By:
- Publication type:
- Article
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events.
- Published in:
- Clinical Chemistry, 2011, v. 57, n. 3, p. 392, doi. 10.1373/clinchem.2010.155333
- By:
- Publication type:
- Article
HDL particle number and size as predictors of cardiovascular disease.
- Published in:
- Frontiers in Pharmacology, 2015, p. 1, doi. 10.3389/fphar.2015.00218
- By:
- Publication type:
- Article
Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer's Disease.
- Published in:
- Neurochemical Research, 2012, v. 37, n. 12, p. 2706, doi. 10.1007/s11064-012-0860-8
- By:
- Publication type:
- Article
Apolipoprotein Aβ: Black Sheep in a Good Family.
- Published in:
- Brain Pathology, 2004, v. 14, n. 4, p. 433, doi. 10.1111/j.1750-3639.2004.tb00088.x
- By:
- Publication type:
- Article
Mildly oxidized LDL particle subspecies are distinct in their capacity to induce apoptosis in endothelial cells: role of lipid hydroperoxides.
- Published in:
- FASEB Journal, 2003, v. 17, n. 1, p. 88, doi. 10.1096/fj.02-0293fje
- By:
- Publication type:
- Article
Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency.
- Published in:
- Antioxidants, 2023, v. 12, n. 8, p. 1498, doi. 10.3390/antiox12081498
- By:
- Publication type:
- Article
Blood Pressure-Lowering Response to Amlodipine as a Determinant of the Antioxidative Activity of Small, Dense HDL3.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 317, doi. 10.2165/11592280-000000000-00000
- By:
- Publication type:
- Article
Reduced Capacity of High-Density Lipoprotein to Acquire Free Cholesterol From Triglyceride-Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 15, p. 1, doi. 10.1161/JAHA.123.034770
- By:
- Publication type:
- Article
HDL-Targeted Therapies During Myocardial Infarction.
- Published in:
- Cardiovascular Drugs & Therapy, 2019, v. 33, n. 3, p. 371, doi. 10.1007/s10557-019-06865-1
- By:
- Publication type:
- Article
Identifying new Risk Markers and Potential Targets: The Value of the Proteome.
- Published in:
- Cardiovascular Drugs & Therapy, 2016, v. 30, n. 1, p. 13, doi. 10.1007/s10557-016-6656-3
- By:
- Publication type:
- Article
Identification of the specific molecular and functional signatures of pre-beta-HDL: relevance to cardiovascular disease.
- Published in:
- Basic Research in Cardiology, 2023, v. 118, n. 1, p. 1, doi. 10.1007/s00395-023-01004-2
- By:
- Publication type:
- Article
Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 2, p. 803, doi. 10.1007/s40744-021-00304-0
- By:
- Publication type:
- Article
HDL particle subpopulations: Focus on biological function.
- Published in:
- Biofactors, 2015, v. 41, n. 2, p. 67, doi. 10.1002/biof.1202
- By:
- Publication type:
- Article
Plasma ubiquinol-10 as a market for disease: is the assay worthwhile?
- Published in:
- Biofactors, 1999, v. 9, n. 2-4, p. 225, doi. 10.1002/biof.5520090217
- By:
- Publication type:
- Article
Whole plasma oxidation assay as measure of lipoprotein...
- Published in:
- Biofactors, 1997, v. 6, n. 2, p. 99, doi. 10.1002/biof.5520060203
- By:
- Publication type:
- Article
Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anti-coagulant, protein S.
- Published in:
- Proteomics - Clinical Applications, 2016, v. 10, n. 3, p. 230, doi. 10.1002/prca.201500062
- By:
- Publication type:
- Article
Why is HDL functionally deficient in type 2 diabetes?
- Published in:
- Current Diabetes Reports, 2008, v. 8, n. 1, p. 51, doi. 10.1007/s11892-008-0010-5
- By:
- Publication type:
- Article
Adipocyte ATP-Binding Cassette G1 Promotes Triglyceride Storage, Fat Mass Growth, and Human Obesity.
- Published in:
- Diabetes, 2015, v. 64, n. 3, p. 840, doi. 10.2337/db14-0245
- By:
- Publication type:
- Article